Steven C Schachter

MD | Neurology


  330 Brookline Ave, Ks-457, Boston
     Massachusetts, 02215-5400
  617-667-4460    617-667-7919 Maps & Directions
Steven C Schachter is a Boston, Massachusetts based neurologist who is specialized in Neurology. His current practice location is 330 Brookline Ave, Ks-457, Boston. Patients can reach him at 617-667-4460 or can fax him at 617-667-7919. Steven C Schachter is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1013940378.
Steven C Schachter specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Steven C Schachter speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Steven C Schachter
Specialization: Neurology
Gender:Male
Credentials: MD
Practice Address:330 Brookline Ave, Ks-457, Boston,
Massachusetts, 02215-5400
Phone:617-667-4460
Fax:617-667-7919
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1013940378
NPI Enumeration Date: 09 Jul, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Steven C Schachter
330 Brookline Ave, Ks-457
Boston, Massachusetts
Zip: 02215-5400
Phone Number: 617-667-4460
Fax Number: 617-667-7919
Patients can reach Steven C Schachter at 330 Brookline Ave, Ks-457, Boston, Massachusetts or can call to book an appointment on 617-667-4460.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.